News and Announcements
Kalium Lakes (ASX: KLL) announces AU$20.8M investment from Greenstone
- Published April 10, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Kalium Lakes (ASX: KLL) has announced an investment of A$20.8 million from Greenstone Resources.
- The investment will fund the Beyondie Project in Western Australia to facilitate its xpansion with key infrastructure purchases.
- The Greenstone funding adds to the current project funding of A$74 million from NAIF and A$102 million from KFW, taking Greenstone’s share in Kalium Lakes to 19.99% once completed.
Kalium Lakes (ASX: KLL) has announced an investment of A$20.8 million from Greenstone, part of the Greenstone Resources II LP Group. The investment will fund the Kalium Lakes’ Beyondie Sulphate of Potash Project (Beyondie Project) in Western Australia.
The funding will be put towards the purchase of long lead items, pond construction, bores, trenches, pumping equipment, accommodation village installation, RFDS airstrip, administration and work-shops. These purchases will help Kalium Lakes to reach its goal of achieving Australia’s first commercial SOP production in 2020.
In addition, Kalium Lakes welcomes experienced Director, Stephen Dennis to the Board, currently a Chairman on five ASX listed Boards.
The Greenstone funding adds to the current project funding of A$74 million from NAIF and A$102 million from KFW. Once completed, Greenstone will hold a 19.99% stake in Kalium Lakes.
Read the ASX Release HERE.
About Kalium Lakes (ASX: KLL)
Kalium Lakes Limited is an exploration and development company, focused on developing the Beyondie Sulphate Of Potash Project in Western Australia with the aim of producing Sulphate of Potash (SOP), a high yield, premium fertiliser, for both domestic and international markets. There is currently no SOP production in Australia.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
